chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Bone pain, Chills, Pain, Pyrexia
Clinical narrative: Severe joint/bone pain; Severe joint/bone pain; Body aches; Low fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0158) via an unspecified route of administration in the left arm on 08Apr2021 at 14:15 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, recovered on an unknown date in Jun2020.Concomitant medication were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 07:00 the patient experienced severe joint pain/bone pain, body aches, low fever and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events joint pain, bone pain, body aches, low fever and chills was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Back pain, Chest pain, Pain in extremity
Clinical narrative: Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 09Apr2021 at 13:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included seizure disorder not otherwise specified. The patient did not take any concomitant medication. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 11Mar2021 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 09Apr2021 at 17:00 the patient experienced Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events moderate muscle pain in left arm, pain in shoulder, back pain, chest pain, abs pain and vaccination site pain were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site.; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the arm left on 09Apr2021 at 13:30 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included seizure disorder not otherwise specified. The patient did not take any concomitant medication. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 11Mar2021 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 09Apr2021 at 17:00 the patient experienced Moderate muscle pain in left arm shoulder, back, chest, and abs. Started locally and has been spreading from vaccination site. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcomes of the events moderate muscle pain in left arm, pain in shoulder, back pain, chest pain, abs pain and vaccination site pain were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hyperhidrosis, Vaccination site pain
Clinical narrative: Extreme fatigue; Full body sweats; Headache; Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 07Apr2021 at 11:45 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. Concomitant medications were not reported. Allergies to medications, food or other products were reported as unknown. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Mar2021 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 12:00, the patient experienced extreme fatigue, full body sweats, headache and injection site pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events extreme fatigue, full body sweats, headache and injection site pain was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Fatigue, Mouth ulceration, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 18:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos disease and COVID-19. Concomitant medication was not reported. The patient was previously allergic to prochlorperazine (COMPAZINE). Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at 08:00, the patient experienced diarrhea, mouth ulceration along gum line, arm pain, shoulder pain and fatigue. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event diarrhea, mouth ulceration along gum line, arm pain, shoulder pain and fatigue were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Back pain, Breast pain, Pain, Pain in extremity
Clinical narrative: My arm was sore at first but within 1 day it got worse; My arm was sore at first but within 1 day it got worse and spread to my armpit; My arm was sore at first but within 1 day it got worse and spread to my armpit, my breast muscle; My arm was sore at first but within 1 day it got worse and spread to my armpit, my breast muscle, and towards my back.; It was a odd pain sore to the touch even my clothes hurt to wear.; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 02Apr2021 at 09:30 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. Medical history included endometriosis and migraines. The patient did not have any allergies to medications, food or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 08:00, the patient experienced arm was sore at first but within 1 day it got worse and spread to arm pit, breast muscle, and towards back. It was a odd pain sore to the touch even the clothes hurt to wear. It finally wore off after about 3 days. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events arm was sore at first but within 1 day it got worse and spread to arm pit, breast muscle, and towards back, it was a odd pain sore to the touch even the clothes hurt to wear were resolved on 06Apr2021.   No follow up attempts are possible; information about lot/batch number cannot be obtained.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever; headache; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW01158) via an unspecified route of administration in the left arm on 08Apr2021 at 15:00 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to coconut and chamomile. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021 at 15:00 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 12:00, the patient experienced fever and headache. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events fever and headache were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Pain, Pyrexia
Clinical narrative: Fever of 101, body aches, chills, dizziness; Body aches; Chills; Dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 08Apr2021 at 08:30(at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24March2021 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08April2021 at 17:30, the patient experienced fever of 101, body aches, chills and dizziness. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever of 101, body aches, chills, dizziness were recovering, at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Our friend received the Pfizervaccine and was feeling tiredafterwards.; This is a spontaneous report from a contactable consumer. A female patient of unknown age received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. On an unknown date, the reporter was speaking to a friend and she said their friend, the patient, received the Pfizer vaccine and experienced feeling tired afterwards. The clinical outcome of the event feeling tired afterwards was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: Phantom smell/ parosmia; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 08Apr2021 at 18:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unknown date in Apr2021, the patient experienced phantom smell, parosmia. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event phantom smell, parosmia was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Vaccinated arm was a bit sore; feel a bit tired; This is a spontaneous report from a contactable consumer. A female patient of an unknown age received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 09Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if the patient was pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 09Apr2021 the patient experienced vaccinated arm was a bit sore and felt a bit tired. It was unknown if the patient received treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events vaccinated arm was a bit sore and felt a bit tired was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Severe joint pain. Knees and Elbows; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm right on 12Mar2021 at 10:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 22Mar2021 at 08:00, the patient experienced severe joint pain, knees and elbows. No therapeutic measures were taken as a result of the reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of severe joint pain, knees and elbows was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Two very swollen lymph nodes in left arm pit; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 08Apr2021(at the age of 36-year-old) as a single dose for COVID-19 immunisation. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced two very swollen lymph nodes in left arm pit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event two very swollen lymph nodes in left arm pit was not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Muscles pain; Joints pain; This is a spontaneous report from a contactable physician. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route in the right arm on 25Jan2021 at 10:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. The patient had no known allergies. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route in the left arm on 06Jan2021 at 10:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 08:00, the patient experienced muscles pain and joints pain. The events did not result in a visit to doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events muscles pain and joints pain was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Chest pain, Diarrhoea, Dysphagia, Feeling hot
Clinical narrative: I felt my heart rate little fast; Burning in my chest; I felt warm in my whole body; Now my GERD is really bad; My stomach is burning; My throat like I can't swallow because I feel like my acid reflux is being agitated; I do not feel good; I have got to throw up; Yesterday morning I had very loose bowels, now this morning again; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know if patient had very bad GERD and does the Pfizer injection of vaccine because the patient had first injection on Tuesday and Tuesday when patient got it, the patient felt warm in whole body, the patient felt heart rate little fast and then it stopped. On 07Apr2021, (Yesterday) morning the patient had very loose bowels, now this morning again and now GERD was really, really bad. The patient's stomach was burning, the patient has burning in chest and throat like patient can't swallow because patient feel like his/her acid reflux was being agitated. The patient wanted to know was this a side effect of the injection because patient did not eat anything that patient should not eat, that patient do not normally eat. And if it has happened to the patient with the first shot, what's going to happen to with the second shot. In response to further probing, patient stated, "No, no patient got to go now because patient do not feel good, patient did not want to answer any more questions okay, patient have got to throw up, okay patient doesn't feel good." And hung up abruptly. The clinical outcome of the events was unknown. Reason for no lot number: of COVID-19 Vaccine: Other: Consumer stated, "It says I can't make out their writing its EB0150 something like that, I can't make out the writing.  No follow up attempts are possible. Information about lot/batch number cannot be requested.
Sex: U
Vaccine: COVID19
Symptoms: Gastrooesophageal reflux disease, Heart rate, Heart rate increased, Malaise, Vomiting
Clinical narrative: I felt my heart rate little fast; Burning in my chest; I felt warm in my whole body; Now my GERD is really bad; My stomach is burning; My throat like I can't swallow because I feel like my acid reflux is being agitated; I do not feel good; I have got to throw up; Yesterday morning I had very loose bowels, now this morning again; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know if patient had very bad GERD and does the Pfizer injection of vaccine because the patient had first injection on Tuesday and Tuesday when patient got it, the patient felt warm in whole body, the patient felt heart rate little fast and then it stopped. On 07Apr2021, (Yesterday) morning the patient had very loose bowels, now this morning again and now GERD was really, really bad. The patient's stomach was burning, the patient has burning in chest and throat like patient can't swallow because patient feel like his/her acid reflux was being agitated. The patient wanted to know was this a side effect of the injection because patient did not eat anything that patient should not eat, that patient do not normally eat. And if it has happened to the patient with the first shot, what's going to happen to with the second shot. In response to further probing, patient stated, "No, no patient got to go now because patient do not feel good, patient did not want to answer any more questions okay, patient have got to throw up, okay patient doesn't feel good." And hung up abruptly. The clinical outcome of the events was unknown. Reason for no lot number: of COVID-19 Vaccine: Other: Consumer stated, "It says I can't make out their writing its EB0150 something like that, I can't make out the writing.  No follow up attempts are possible. Information about lot/batch number cannot be requested.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: a rash all over body and now face; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 at 09:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 the patient experienced a rash all over body and now face. The patient did not receive treatment for the event. Patient stated that she didn't handle anything that was out of the usual or eat anything new. Also, stated she was going to try over the counter BENADRYL and see if it relieved the symptoms. Patient questioned was that something she should be alarmed about, and is it possible this was an effect caused by the vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event rash all over body and now face was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash erythematous
Clinical narrative: Red itchy sunburn looking rash from chin to thighs; Red itchy sunburn looking rash from chin to thighs; Red itchy sunburn looking rash from chin to thighs; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old patient of unknown gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 13:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included dry eye (both forms of chronic dry eye) and meibomian gland disorder. Concomitant medications included fish oil (MANUFACTURER UNKNOWN), maqui berry, probiotic and colecalciferol, calcium carbonate (CALCIUM D3) all for an unknown indication started on an unknown date. The patient was allergic to sulfa drugs, latex, band aids adhesive. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:00, the patient experienced red itchy sunburn looking rash from chin to thighs. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events redness, itchy, sunburn looking rash from chin to thighs was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Nausea, Vomiting approximately 25 hours after vaccination; Nausea, Vomiting approximately 25 hours after vaccination; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 09Apr2021 at 13:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history and known allergies to food, medicine or other products was reported as not available. Medications taken within two weeks prior to the vaccination included medication for birth control (unspecified). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 15:00, the patient experienced nausea, vomiting approximately 25 hours after vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of nausea, vomiting approximately 25 hours after vaccination and included general care. The clinical outcome of the events nausea, vomiting approximately 25 hours after vaccination was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Headache, Malaise
Clinical narrative: Fatigue; Muscle burning; Low-grade fever; Headache; Muscle pain; Chills; Tiredness; Feeling unwell; Feeling unwell and weak; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 08Apr2021 at 16:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity 35.5 Body Mass Index (BMI), cholecystectomy and thyroid nodules. The patient had no allergies to medications, food, or other products. The patient received unspecified concomitant medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced fatigue, muscle burning, low-grade fever, headache, muscle pain, chills, tiredness, felt unwell and weak. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events fatigue, muscle burning, low-grade fever, headache, muscle pain, chills, tiredness, felt unwell and weak were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Fatigue; Muscle burning; Low-grade fever; Headache; Muscle pain; Chills; Tiredness; Feeling unwell; Feeling unwell and weak; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 08Apr2021 at 16:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity 35.5 Body Mass Index (BMI), cholecystectomy and thyroid nodules. The patient had no allergies to medications, food, or other products. The patient received unspecified concomitant medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced fatigue, muscle burning, low-grade fever, headache, muscle pain, chills, tiredness, felt unwell and weak. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events fatigue, muscle burning, low-grade fever, headache, muscle pain, chills, tiredness, felt unwell and weak were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lymphadenopathy, Tachycardia
Clinical narrative: Severe fatigue; Headaches; Severe chills; Tachycardia; Adenopathy; This is a spontaneous report from a contactable consumer. This 31-year-old female consumer.  A 35-year-old (non-pregnant) female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Er8737, Expiration date: unknown), via unspecified route, administered in left arm on 08Apr2021 10:00 am (at the age of 35-year-old) as DOSE 2, SINGLE for COVID-19 immunization. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Er8727, Expiration date: unknown), via unspecified route, administered in left arm on 18Mar2021 at 10:00 am (at the age of 35-year-old) as DOSE 1, SINGLE for COVID-19 immunization from workplace clinic. The patient medical history and concomitant medications were not reported. No other vaccines administered in four weeks. No other medications administered in two weeks. Patient was not diagnosed with covid prior vaccination and was not tested for covid post vaccination. No allergies reported.  On 08Apr2021, after the vaccination, the patient experienced Severe fatigue, Headaches, Severe chills, Tachycardia and lymphadenopathy. Events resulted in healthcare professional office visit. Treatment was initiated with ibuprofen. The outcome of the events is recovering at the time of report.  No follow-up attempts possible. No further information expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: fast heartbeat/heart rate was too high; This is a spontaneous report from a contactable consumer (parent). A 20-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported, NDC number and Expiry date were not provided), via an unspecified route of administration on 05Apr2021 at the age of 20-years-old as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient reported on behalf of her daughter (patient) who received the 1st dose of the Pfizer covid vaccine on Monday, 5Apr2021. The previous day, she went to donate blood as she usually does. However, she was denied due to a fast heartbeat on an unspecified date. She hasn't ever been declined in the past. She walked to the place as she usually does. Stated that they told her that her heart rate was too high on an unspecified date. Stated that they took it a second time and it was too high for them to take her blood. Stated that her daughter normally has low blood pressure like her and had to stay there afterwards for a little while so she will not pass out. The reporter wanted to know if the heart rate would be associated with the blood pressure. Wanted to know if this could be from the vaccine even though she had it back on 05Apr. Clarified that she had the Covid 19 vaccination. Wanted to know if her daughter needed to go and get this checked out. patient would like to know whether her daughter should ask the vaccination provider to take her blood pressure when she returns for the 2nd dose of the covid vaccine and was Informed that it is not a recommendation of Pfizer's but she may request it at the vaccination providers discretion. Patient wanted to know whether her daughters side effect: a fast heartbeat, was related to the covid vaccine. Patient would like to know whether there are any reporting to do for her daughters experience. Reporter seriousness for heart rate was too high was unspecified. The outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: resting heartrate 130 beats per minute; This is a spontaneous report from a contactable consumer or other non-HCP. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on Apr2021 as DOSE 2 ,SINGLE (Age of vaccination: Unknown) for covid-19 immunization. Historical vaccine included first dose of BNT162B2 (COMIRNATY, Solution injection, Lot number/Expiration date: Unknown) for covid-19 immunization. Medical history included blood donation. The patient's concomitant medications were not reported. On an unspecified date of Apr2021 the patient experienced resting heartrate 130 beats per minute. The patient underwent lab tests and procedures which included heart rate: 130 bpm on Apr2021 130 BPM. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arms; This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: unknown), via an unspecified route of administration on an unspecified date as dose 1, single and second dose of BNT162b2, (Lot Number: Unknown), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date, the patient experienced sore arm. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Heart rate increased, Hyperhidrosis, Rash, Vomiting
Clinical narrative: Very fast heart beat; Feel burning Inside; Sweating; Rash on face; Vomiting; This is a spontaneous report from a contactable consumer or other non health professional (patient). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Batch/Lot number: Not reported) via an unspecified route of administration, administered on 14Apr2021 as a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that on 14Apr2021 the patient got the Pfizer shot of first one and on 15Apr2021 patient had side effects somewhere like very fast heartbeat and then patient feel like burning inside and feel like sweating and patient was throwing up and also had like rash on face not all over the body but only on face. So patient was not sure if that was okay or was not okay. And further reported that patient had vomiting too. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Thyroid disorder
Clinical narrative: she developed swollen lymph nodes, primarily under my left arm where the vaccine was given, and also had a mass on my thyroid, left thyroid; she developed swollen lymph nodes, primarily under my left arm where the vaccine was given, and also had a mass on my thyroid, left thyroid; This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: not reported, Expiration date: not reported) via an unspecified route of administration, administered in Arm Left on an unspecified date as DOSE 2, SINGLE for covid-19 immunization. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot number: not reported, Expiration date: not reported) via an unspecified route of administration, administered in Arm Left on an unspecified date as DOSE 1, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced swollen lymph nodes, primarily under left arm where the vaccine was given, and had a mass on thyroid, left thyroid. Caller stated she had never had a history of thyroid issues before receiving the vaccine. The outcome of events was reported as unknown at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Heart rate irregular
Clinical narrative: heartbeat is fluctuation between 115-130; This is a spontaneous report from a contactable consumer (patient) and from a Pfizer sponsored program (NCSP:159558). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiry date: Unknown) via an unspecified route of administration on 18Apr2021 as Dose 2, Single for Covid-19 immunization. The patient medical history and concomitant medications were not reported. On an 18Apr2021 the patient experienced heartbeat is fluctuation between 115-130. The patient underwent lab tests and procedures which included heart rate irregular: 115-130  on 18Apr2021 (yesterday) heartbeat is fluctuation between 115-130. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Pyrexia, Tachycardia
Clinical narrative: He felt weird; A lot of tachycardia with his heart 15 or 20 minutes; Fever; Headache; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 43-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration on 22Apr2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 first dose of (PFIZER-BIONTECH COVID-19 VACCINE) for covid-19 immunisation. Patient received the second dose of the vaccine yesterday. Patient having symptoms at this moment. A couple hours after the vaccine he felt weird and had a lot of tachycardia with his heart for 15 or 20 minutes on 22Apr2021. He rested and today he feels the same (still having tachycardia). He got a fever last night and a headache and the other symptoms that are normal on Apr2021. He asked if the tachycardia is normal and if he needs to see a specialist? The outcome of the event tachycardia was not recovered and unknown for another events.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Heart rate increased, Myopia
Clinical narrative: fast heartbeat; dizziness; weakness; had trouble seeing; This is a spontaneous report from a contactable consumer(patient). A 35-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date was not reported), via an unspecified route of administration at the age of 35-year old on 06Apr2021 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient stated that after receiving the vaccine he had an immediate fast heartbeat, dizziness and weakness, and had trouble seeing and it lasted about 12 minutes. He experienced no swelling of the face and throat. Symptoms resolved within 12 minutes. He did not seek any medical attention while at the vaccination clinic. He had spoken with his primary care doctor and his doctor said it was fine to take. He did however see online that his side effects could be contraindications for the second dose. He was calling for a second opinion. The outcome of events was recovered on an unspecified date in 2021. No Follow-up attempts are needed. Information about lot/batch number cannot be obtained.